ArticleIJU case reports2026

Pseudoprogression During Enfortumab Vedotin Plus Pembrolizumab Therapy in Muscle-Invasive Bladder Cancer Achieving Pathological Complete Response: A Case Report.

Yosuke Nakanishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.